ReShape Lifesciences Inc. (RSLS)
Aug 15, 2025 - RSLS was delisted (reason: merged into HIND)
15.68
0.00 (0.00%)
Inactive · Last trade price
on Aug 14, 2025
ReShape Lifesciences Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$358,444
Profits / Employee
-$249,889
Market Cap
10.56M
Employees Chart
RSLS News
- 4 weeks ago - Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation - GlobeNewsWire
- 4 months ago - Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow - Business Wire
- 4 months ago - Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND - Business Wire
- 4 months ago - Vyome Announces New Board of Directors with Deep MIT and AI Ties - Business Wire
- 4 months ago - ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - Business Wire
- 4 months ago - ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 4 months ago - ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewsWire
- 4 months ago - ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewsWire